SYNLAB AG (SYAB.F)

10.42 -0.04 (-0.38%) 收市：03:59PM CEST

SYNLAB AG

Moosacher Straße 88
Munich 80809
Germany
49 89 307602 0
https://www.synlab.com

版塊: Healthcare
行業: Diagnostics & Research
全職員工: 23,538

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Mathieu Floreani	Chairman of the Management Board & CEO	2.39M	無	1967
Dr. Bartholomäus Wimmer	Founder & Independent Member of the Supervisory Board	132k	無	1962
Mr. Sami Badarani	CFO & Member of Management Board	1.5M	無	1963
Mr. Robert Steinwander	Group Chief Operating Officer	無	無	無
Mr. Henrik Andreasen	Group Chief Information Officer	無	無	無
Dr. Anna Niedl	Head of Investor Relations	無	無	無
Ms. Kimberly Urdahl	Group General Counsel & Group Chief Compliance Officer	無	無	無
Alexander Hagen	Group Head of Commercial & Marketing	無	無	無
Ms. Catharina Monster	Group Chief Human Resources Officer	無	無	無
Mr. Luis Vieira	Group Chief Strategy Officer	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 EUR。

描述

SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers medical and veterinary diagnostics services. SYNLAB AG was founded in 1998 and is headquartered in Munich, Germany.

公司管治

截至 無 止，SYNLAB AG 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。